Verastem VSTM
$6.33 −$0.53 (-7.73%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $6.39 +0.95%
Open$6.63
Prev close$6.86
Day range$6.25 – $6.82
Volume3.25M
Market cap$797.67M
P/E (TTM)–
Dividend yield–
VSTM Stock News
Headlines matching Verastem or the VSTM ticker, most recent first.
- RBC Capital Maintains Verastem(VSTM.US) With Buy Rating, Maintains Target Price $14
- Wolfe Research Maintains Verastem(VSTM.US) With Buy Rating
- A Quick Look at Today's Ratings for Verastem(VSTM.US), With a Forecast Between $12 to $18
- Mizuho Securities Maintains Verastem(VSTM.US) With Buy Rating, Cuts Target Price to $13 Negative
- RBC Capital Maintains Verastem(VSTM.US) With Buy Rating, Cuts Target Price to $14 Negative
- A Quick Look at Today's Ratings for Verastem(VSTM.US), With a Forecast Between $14 to $18
- Analysts Offer Insights on Healthcare Companies: Atai Beckley N.V. (ATAI), Madrigal Pharmaceuticals (MDGL) and Verastem (VSTM)
- A Quick Look at Today's Ratings for Verastem(VSTM.US), With a Forecast Between $8 to $18
- Mizuho Securities Maintains Verastem(VSTM.US) With Buy Rating, Maintains Target Price $14
- BTIG Maintains Verastem(VSTM.US) With Buy Rating, Cuts Target Price to $18 Negative
- H.C. Wainwright Keeps Their Buy Rating on Verastem (VSTM)
- RBC Capital Maintains Verastem(VSTM.US) With Buy Rating, Maintains Target Price $15
- H.C. Wainwright Sticks to Their Buy Rating for Verastem (VSTM)
- Verastem (VSTM) Receives a Buy From B. Riley Securities
- Mizuho Securities Maintains Verastem(VSTM.US) With Buy Rating, Cuts Target Price to $14 Negative
No comments yet — be the first to weigh in on VSTM.
Sign in to join the discussion.